Psychemedics Corporation (PMD)
NASDAQ · Healthcare
Psychemedics Corporation Income Statement 2020–2024
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | 21.4M | 24.9M | 25.2M | 22.1M | 19.7M |
| Gross Profit | 4.9M | 10.3M | 9.3M | 8.4M | 7.1M |
| Profitability | |||||
| Operating Income | -6.1M | 209,000 | -1.1M | -2.9M | -1.9M |
| EBITDA | -2.4M | 4.9M | 2.2M | 256,000 | 193,000 |
| Net Income | -3.9M | -665,000 | -1.1M | -4.2M | -1.9M |
| Per Share Data | |||||
| EPS (diluted) | $-0.70 | $-0.12 | $-0.19 | $-0.72 | — |
| Shares Outstanding (dil.) | 6M | 6M | 6M | 6M | — |
Psychemedics Corporation Income Statement — FAQ
Psychemedics Corporation (PMD) income statement over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PMD's income statement history?
The chart and table above show Psychemedics Corporation's income statement by year and by quarter, including the growth rate.